Elanco Animal Health will take part in SIAVS 2024, the International Animal Protein Exhibition, from August 6 to 8 in S\u00e3o Paulo (SP), showcasing its portfolio of preventive solutions for swine and poultry production in Brazil. \u201cWe will present a product pipeline that addresses the main trends in the global swine and poultry production chains,\u201d says Tha\u00eds Vieira, Elanco\u2019s Monogastrics Marketing Manager in Brazil.<\/p>\n
Among the strategies highlighted by Tha\u00eds is the use of a unique and innovative vaccine for the control of post weaning diarrhea in piglets. This solution aims to position customers who adopt the technology at a differentiated level by acting proactively in relation to future market changes and trends. Another approach is the use of vaccines administered via drinking water, which promote ease of application and animal welfare, combined with product efficacy and safety. Finally, there is a strong focus on the nutritional line, which complements Elanco\u2019s portfolio with the concept of solutions from all angles, offering different products and integrated approaches.<\/p>\n
\u201cOur presence at SIAVS reinforces one of Elanco\u2019s main differentiators, which is the value proposition of its solutions, combined with innovation, field presence, technical expertise and high impact projects that go far beyond product sales, including data analysis and sustainability in the sector,\u201d says Tha\u00eds.<\/p>\n
Trends put into practice<\/strong><\/p>\n In vaccines, Elanco offers the only oral vaccine available in the Brazilian market specifically focused on controlling post weaning diarrhea in piglets, Coliprotec\u2122 F4\/F18. The vaccine is certified in animal welfare, as it ensures rapid protection seven days after application and is administered orally to piglets from 18 days of age. In poultry production, within the Salmonella control line, the company developed AviPro\u2122 Megan\u2122 Vac 1, a live vaccine for broilers with a single dose, applied via spray at the hatchery, inducing mucosal immunity and effectively protecting birds during the most critical period for Salmonella infection. \u201cThese are examples of our innovation in vaccines,\u201d says Tha\u00eds.<\/p>\n Regarding nutritional products for poultry and swine, Elanco offers solutions that promote better intestinal integrity with a positive impact on animal performance. One example is Hemicell\u2122 HT, an energy saving enzyme that eliminates compounds that interfere with intestinal quality in poultry and swine. Another is Protexin\u2122 Concentrate, a probiotic additive that supports the balance of intestinal microbiota in both species.<\/p>\n In the field, Elanco works with low cost and high impact projects for farms and animal welfare, such as the Pre Slaughter Program for swine, which helps producers reduce incidents and can lower pig mortality rates by up to three times at this stage. Another highlight is the Health Tracking System HTSi, a health monitoring and data analysis tool for broilers and laying hens in commercial farms. This unique platform collects and analyzes data to support important decision making in poultry companies, such as the choice of anticoccidial or vaccination protocols. HTSi is currently an extensive global database on poultry health, covering more than one million animals and used in several countries, providing effective support for selecting the best preventive and therapeutic strategies.<\/p>\n \u201cAt SIAVS, our team will be available to discuss the impact of innovations like these on animal health and welfare and, consequently, on the productivity and sustainability of Brazilian farms,\u201d says Tha\u00eds.<\/p>\n Elanco Animal Health currently holds the certification \u201cAnimal Welfare Friendly Company,\u201d granted by the auditing organization Fair Food, which is awarded only to companies whose portfolios and internal processes comply with universal animal welfare principles.<\/p>\n To learn more about Elanco in agribusiness, visit agropecuaria.elanco.com and follow the company on LinkedIn and Instagram.<\/p>\n <\/p>\n Service<\/strong><\/p>\n SIAVS 2024 \u2013 International Animal Protein Fair<\/strong><\/p>\n Date: August 6 to 8<\/p>\n Location: Anhembi, Rua Olavo Fontoura 1209, S\u00e3o Paulo, SP<\/p>\n Information: https:\/\/siavs.com.br\/<\/p>\n \u00a0<\/strong><\/p>\n About Elanco\u00a0<\/strong><\/p>\n Elanco Animal Health, listed on the NYSE under the symbol ELAN, is a global leader in animal health. The company is dedicated to innovating and delivering products and services to prevent and treat diseases in food producing animals and companion animals, adding value to the work of producers, pet owners, veterinarians and society as a whole. With nearly 70 years of experience in the sector, Elanco is committed to helping customers improve the health of the animals under their care while making a meaningful impact in local and global communities. Elanco is driven by its vision, Food and Companionship Enriching Life, and by its corporate responsibility framework, Elanco Healthy Purpose\u2122, all focused on improving the health of animals, people and the planet.TM<\/sup> \u2013 everything to improve the health of animals, people, and the planet.<\/p>\n <\/p>\n PRESS INFORMATION\u00a0<\/strong><\/p>\n Develop Strategy<\/strong><\/p>\n Gisele Berto <\/strong>gisele@elaboreestrategia.com.br<\/a> \u2013 (11) 97016-4446
\nLuciana Tardioli <\/strong>luciana@elaboreestrategia.com.br<\/a> \u2013 (11) 97350-6928
\nVanessa Costa <\/strong>vanessa@elaboreestrategia.com.br<\/a> \u2013 (11) 98584-1072<\/p>\n